MyD88 Signaling in the CNS Is Required for Development of Fatty Acid-Induced Leptin Resistance and Diet-Induced Obesity  by Kleinridders, André et al.
Cell Metabolism
Article
MyD88 Signaling in the CNS Is Required
for Development of Fatty Acid-Induced
Leptin Resistance and Diet-Induced Obesity
Andre´ Kleinridders,1,2,3,5 Dominik Schenten,4,5 A. Christine Ko¨nner,1,2,3,5 Bengt F. Belgardt,1,2,3,5 Jan Mauer,1,2,3
Tomoo Okamura,1,2,3 F. Thomas Wunderlich,1,2,3 Ruslan Medzhitov,4 and Jens C. Bru¨ning1,2,3,*
1Department of Mouse Genetics and Metabolism, Institute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging
Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC), University of Cologne, D-50674 Cologne, Germany
22nd Department for Internal Medicine, University Hospital Cologne, D-50674 Cologne, Germany
3Max Planck Institute for the Biology of Ageing, D-50674 Cologne, Germany
4Howard Hughes Medical Institute and Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
5These authors contributed equally to this work
*Correspondence: jens.bruening@uni-koeln.de
DOI 10.1016/j.cmet.2009.08.013SUMMARY
Obesity-associated activation of inflammatory path-
ways represents a key step in the development of
insulin resistance in peripheral organs, partially via
activation of TLR4 signaling by fatty acids. Here, we
demonstrate that palmitate acting in the central
nervous system (CNS) inhibits leptin-induced
anorexia and Stat3 activation. To determine the func-
tional significance of TLR signaling in the CNS in the
development of leptin resistance and diet-induced
obesity in vivo, we have characterized mice deficient
for the TLR adaptor molecule MyD88 in the CNS
(MyD88DCNS). Compared to control mice, MyD88DCNS
mice are protected from high-fat diet (HFD)-induced
weight gain, from the development of HFD-induced
leptin resistance, and from the induction of leptin
resistance by acute central application of palmitate.
Moreover, CNS-restricted MyD88 deletion protects
from HFD- and icv palmitate-induced impairment of
peripheral glucose metabolism. Thus, we define
neuronal MyD88-dependent signaling as a key regu-
lator of diet-induced leptin and insulin resistance
in vivo.
INTRODUCTION
The vast majority of obese patients develop obesity in the pres-
ence of increased circulating plasma leptin concentrations indic-
ative of leptin resistance in these subjects (Frederich et al., 1995).
Similarly, mice exposed to high-fat diet (HFD) as a model of
obesity develop hyperphagia in the presence of increased
plasma leptin concentrations. In addition to reduced transport
of leptin across the blood/brain barrier, impaired neuron-auton-
omous leptin action causes leptin resistance (El-Haschimi et al.,
2000). Nevertheless, the molecular mechanisms underlying lep-
tin resistance under conditions of obesity remain elusive.
Impairment of leptin-stimulated JAK2 activation and subse-
quent Stat3 and PI3k signaling have been shown to result fromCelincreased expression and activation of inhibitors of leptin
signaling, such as suppressor of cytokine signaling (SOCS) 3 or
the protein tyrosine phosphatase PTP-1b (Bence et al., 2006;
Bjorbaek et al., 1999). Accordingly, CNS-wide and POMC-
neuron-restricted SOCS-3 ablation, as well as CNS-wide abla-
tion of PTP-1b, protects from high-fat diet-induced leptin resis-
tance (Bence et al., 2006; Kievit et al., 2006; Mori et al., 2004).
In addition to the occurrence of leptin resistance, obesity is
also characterized by the development of insulin resistance in
the CNS (Belgardt et al., 2008; Plum et al., 2005, 2006a).
Because insulin action in the CNS contributes not only to control
of body weight (Bruning et al., 2000; Schwartz and Porte, 2005;
Schwartz et al., 2000;Woods et al., 1979), but importantly also to
control of peripheral glucose metabolism (Koch et al., 2008;
Konner et al., 2007; Obici et al., 2002), central insulin resistance
represents an important aspect in the pathophysiology of the
metabolic syndrome.
The last decade has revealed important new insights into the
role of innate immune response pathways in the development
of obesity-associated peripheral insulin resistance. Both macro-
phage recruitment to white adipose tissue and adipocyte-
autonomous release of proinflammatory cytokines result in the
activation of JNK- and IKK-signaling pathways, which interfere
with insulin signaling in classical insulin target tissues such as
liver and skeletal muscle (Arkan et al., 2005; Cai et al., 2005;
Hirosumi et al., 2002; Hotamisligil et al., 1993; Rohl et al.,
2004; Shoelson et al., 2003; Uysal et al., 1997; Weisberg et al.,
2003; Wunderlich et al., 2008; Xu et al., 2003). Both pharmaco-
logical and genetic intervention with these signaling pathways
have been shown to improve glucose metabolism (Arkan et al.,
2005; Cai et al., 2005; Hirosumi et al., 2002; Hotamisligil et al.,
1993; Shoelson et al., 2003; Uysal et al., 1997; Wunderlich
et al., 2008). Moreover, metabolic disturbances associated
with obesity, such as hyperlipidemia and hyperglycemia, also
activate JNK, IKK, and atypical PKCs (Chibalin et al., 2008;
Hirosumi et al., 2002; Shoelson et al., 2003).
Saturated fatty acids can also serve as ligands for TLR4 in
addition to the well-characterized bacterial lipopolysaccharides
initially identified as TLR ligands (Lee et al., 2001; Shi et al., 2006).
Mice with either targeted disruption or naturally occurring muta-
tions of TLR4 are protected from obesity-associated insulinl Metabolism 10, 249–259, October 7, 2009 ª2009 Elsevier Inc. 249
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2007). Interestingly, geneticmodels interfering with inflammatory
signaling, such as conventional JNK1- and TLR4-deficient mice,
are not only protected from the occurrence of obesity-associ-
ated insulin resistance, but also fromweight gain, although these
effects have so far not been studied in greater detail (Hirosumi
et al., 2002). More recently, activation of inflammatory signaling
has also been detected in the hypothalamus of obese rats
Figure 1. Acute Application of Palmitate Induces Leptin Resistance
in the CNS
(A) Food intake of 10-week-old, overnight fasted male C57/BL6 mice, which
were intracerebroventricularly (ICV) injected with either vehicle (BSA) or palmi-
tate at different concentrations (10, 20, 50, and 66 pmol), followed by refeeding
for 4 hr ad libitum on normal diet.
(B) Food intake of 10-week-old, overnight fasted male C57/BL6 mice, which
were ICV injected with either vehicle (BSA) or palmitate (66 pmol) 30 min prior
to ICV injection of leptin (500 ng) or the respective vehicle (0.9% saline), fol-
lowed by refeeding for 4 hr ad libitum on normal diet.
(C) (Left) Representative western blot analysis of phosphorylated STAT3 and
STAT3 (n = 3) in dissected arcuate nuclei of 10-week-old, overnight fasted
male C57/BL6 mice, which were ICV injected with either vehicle (BSA) or
palmitate (66 pmol) 30min prior to ICV injection of leptin (500 ng) or the respec-
tive vehicle (0.9% saline). (Right) Densitometrical analysis of phosphorylated
STAT3 of palmitate- + leptin-injectedmice (n = 7) as compared tomice injected
with BSA + leptin (n = 6).
Displayed values are means ± SEM. *p% 0.05, **p% 0.01, and ***p% 0.001.250 Cell Metabolism 10, 249–259, October 7, 2009 ª2009 Elsevier I(De Souza et al., 2005). It was subsequently demonstrated that
inhibiting IKK2 action in the CNS (Zhang et al., 2008) or amelio-
rating ER-stress activation in the CNS (Ozcan et al., 2009)
prevents neuronal leptin resistance, and two very recent studies
indicated that short-term pharmacological inhibition of neuronal
TLR signaling inhibits fatty acid-induced insulin (Posey et al.,
2009) and leptin resistance (Milanski et al., 2009).
MyD88 is an essential signaling adaptor for most TLRs and for
members of the IL-1 receptor family (Kawai et al., 1999). TLR4
signaling specifically depends on the signaling adaptor TRIF in
addition to MyD88. However, whereas TRIF is required for
the induction of TLR3- and TLR4-induced type I interferons,
MyD88 is essential for the induction of proinflammatory cyto-
kines (Kawai and Akira, 2006; Yamamoto et al., 2003). Therefore,
we have generated and analyzed mice that carry a CNS-specific
ablation of MyD88 in order to address the role of fatty acids
acting in the CNS in general and, specifically, TLR-mediated
MyD88-dependent signaling in the development of obesity and
obesity-associated insulin resistance.
RESULTS
Palmitate Can Induce Leptin Resistance in the CNS
To directly address whether saturated fatty acids can impair
central leptin action in vivo, we aimed to investigate the acute
pharmacological effect of intracerebroventricularly (icv)-applied
palmitate on the anorectic effect of leptin. First, we monitored
whether different doses of palmitate affected food intake in a
refeeding paradigm. This analysis revealed that, in a range of
10–66 pmol, icv palmitate had no acute effect on food intake
compared to injection of the BSA carrier solution (Figure 1A).
Next, we confirmed that injection of carrier solution 30 min prior
to leptin application compared to carrier solution application
followed by saline injection resulted in a significant reduction of
food intake by 60% (Figure 1B), comparable to the described
acuteanorecticeffect of icv leptin treatment incontrolmice (Mistry
et al., 1997). However, although injection of 66 pmol palmitate
prior to saline injection resulted in a comparable food intake, as
observed in animals receiving saline injection after BSA injection
(Figure 1B), leptin injection following pretreatment with palmitate
failed to significantly reduce food intake in thesemice (Figure 1B).
Next, we addressed whether icv palmitate treatment directly
affects leptin-evoked hypothalamic signaling. Therefore, we
investigated leptin’s ability to activate Stat3 phosphorylation
after icv pretreatment of mice with either BSA-containing carrier
solution or 66 pmol palmitate. Whereas leptin stimulation subse-
quent to an icv injection of BSA carrier profoundly activated
Stat3 phosphorylation in the hypothalamus of mice (Figure 1C),
this response was blunted by 60% after icv palmitate treatment
(Figure 1C). Taken together, these experiments indicate that
palmitate treatment acutely inhibits both leptin-evoked Stat3
phosphorylation and leptin-induced anorexia in vivo.
Generation of MyD88DCNS Mice
In peripheral tissues, fatty acids have been demonstrated to
cause insulin resistance and to activate inflammatory pathways
in a TLR4-dependent manner (Shi et al., 2006). Thus, we next
aimed to directly address the contribution of TLR-dependent
signaling in the CNS to the development of fatty acid-inducednc.
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end, we generatedmice that carry a CNS-specific ablation of the
principal TLR adaptor molecule MyD88 (MGI: 108005), which is
essential for both TLR-dependent JNK and IKK activation
(Figure S1A available online) (Adachi et al., 1998; Janssens and
Beyaert, 2002).
Western blot analysis revealed strongly reduced amounts of
immunoreactive MyD88 protein in extracts isolated from brain
of brain-specific MyD88 knockout (MyD88DCNS) mice compared
to control animals (Figure S1B), whereas MyD88 expression
remained unaltered in peripheral tissues of MyD88DCNS mice
compared to controls (Figure S1C), thus demonstrating the
successful generation of brain-specific MyD88 knockout mice.
Normal Energy Homeostasis in MyD88DCNS Mice
To investigate whether deletion of MyD88 in the CNS affected
body weight regulation or glucose metabolism in mice exposed
to normal chow diet, we next monitored parameters of energy
Figure 2. MyD88DCNS Mice Are Protected from
Diet-Induced Obesity
(A) Average body weight of male control and MyD88DCNS
mice on normal chow diet (NCD) (n = 12–15) and high-fat
diet (HFD) (n = 11–13) at the age of 16 weeks.
(B) Average bodyweight of female control andMyD88DCNS
mice on NCD (n = 12–14) and HFD (n = 7–12) at the age of
16 weeks.
(C) Naso-anal body length of male control andMyD88DCNS
mice on NCD (n = 15) and HFD (n = 19–21) at the age of 16
weeks.
(D) Naso-anal body length of female control and
MyD88DCNS mice on NCD (n = 12–14) and HFD (n = 12–18)
at the age of 16 weeks.
(E) Epididymal fat pad weights of male control and
MyD88DCNS mice on NCD (n = 15) and HFD (n = 19–21)
at the age of 16 weeks.
(F) Parametrial fat pad weights of female control and
MyD88DCNS mice on NCD (n = 12–14) and HFD (n = 12–18)
at the age of 16 weeks.
(G) H&E stain of epididymal/parametrial adipose tissue of
male and female control and MyD88DCNS mice on NCD
and HFD at the age of 16 weeks. Scale bar, 100 mm.
(H) Quantification of mean adipocyte surface in epidid-
ymal/parametrial adipose tissue of male (n = 3–5) and
female (n = 3–5) control and MyD88DCNS mice on NCD
and HFD at the age of 16 weeks.
Displayed values aremeans ± SEM. *p% 0.05, **p% 0.01,
***p% 0.001.
homeostasis and glucose metabolism in
MyD88DCNS mice compared to controls. These
analyses revealed unaltered body weight,
body length, and epigonadal fat pad mass, as
well as unaltered histomorphological appear-
ance of white adipose tissue (WAT) in
MyD88DCNS mice compared to controls both in
male and female mice at the age of 16 weeks
(Figures 2A–2H). Similarly, analysis of blood
glucose and plasma insulin concentrations, as
well as glucose and insulin tolerance tests,
revealed unaltered glucose metabolism in
MyD88DCNS compared to control mice (Figures
3A–3F). Taken together these experiments indicate that
MyD88-dependent signaling in the CNS is dispensable for main-
tenance of body weight and glucose homeostasis in lean mice.
MyD88DCNS Mice Are Protected from HFD-Induced
Weight Gain
To directly investigate the role of MyD88-dependent signaling in
the CNS in the development of diet-induced obesity, we next
monitored body weight in control and MyD88DCNS mice, which
were exposed toHFD from3weeksof age on. Strikingly,whereas
HFD-induced weight gain was significantly attenuated in male
MyD88DCNS mice compared to control mice (Figures 2A and
S2A), it was completely abolished in female MyD88DCNS mice
(Figures 2B and S2B). Similarly, whereas high-fat feeding
increased body length in control mice, presumably via impair-
ment of MC4R action (Yaswen et al., 1999; Huszar et al., 1997),
this effect was abolished in MyD88DCNS mice (Figures 2C and
2D). Whereas epigonadal fat padmass was only slightly reducedCell Metabolism 10, 249–259, October 7, 2009 ª2009 Elsevier Inc. 251
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CNS-Restricted MyD88 KnockoutFigure 3. Improved Glucose Metabolism in MyD88DCNS Mice on High-Fat Diet
(A) Intraperitoneal glucose tolerance test in male control andMyD88DCNS mice on normal chow diet (NCD) (n = 13–14) and high-fat diet (HFD) (n = 11) at the age of
11 weeks.
(B) Intraperitoneal glucose tolerance test in female control and MyD88DCNS mice on NCD (n = 9–19) and HFD (n = 7–12) at the age of 11 weeks.
(C) Intraperitoneal insulin tolerance test in male control and MyD88DCNS mice on NCD (n = 13–14) and HFD (n = 11–13) at the age of 12 weeks.
(D) Intraperitoneal insulin tolerance test in female control and MyD88DCNS mice on NCD (n = 9–19) and HFD (n = 7–12) at the age of 12 weeks.
(E) Serum insulin levels of male control and MyD88DCNS mice on NCD (n = 8–10) and HFD (n = 11–13) at the age of 16 weeks.
(F) Serum insulin levels of female control and MyD88DCNS mice on NCD (n = 4–6) and HFD (n = 7–12) at the age of 16 weeks.
Displayed values are means ± SEM. *p% 0.05, **p% 0.01.in male MyD88DCNS mice (Figure 2E) and overall fat content re-
mained unaltered inmaleMyD88DCNSmice compared to controls
(Figure S2C), female MyD88DCNS mice exhibited a significant
60% reduction in the amount of parametrial fat mass (Figure 2F)
and a significant 24% reduction in body fat content (Figure S2D)
compared to controls upon high-fat feeding. Unlike in control
mice, in which exposure to high-fat diet resulted in significant
enlargement of adipocytes in WAT in both control male and
female mice, adipocyte hyperplasia upon high-fat feeding was
completely prevented in MyD88DCNS mice of both genders
(Figures 2G and 2H). Taken together, brain-specific disruption
of MyD88 protects from HFD-induced weight gain, increase in
body length, and WAT remodeling in both genders, whereas it
prevents overall fat accumulation only in female mice.
Improved Energy Homeostasis in MyD88DCNS Mice
To investigate the mechanism(s) underlying protection from
HFD-induced weight gain in MyD88DCNS mice, we next moni-252 Cell Metabolism 10, 249–259, October 7, 2009 ª2009 Elsevier Itored caloric intake of these animals both at the age of 4 weeks,
when body weights between controls and MyD88DCNS mice
were still indistinguishable, and at the age of 12 weeks, when
MyD88DCNS mice showed already reduced body weight com-
pared to controls. Whereas both male and female MyD88DCNS
mice exhibited a trend toward reduced food intake at 4 weeks
of age, only male MyD88DCNS mice consumed significantly less
food compared to controls at the age of 12 weeks (Figures 4A
and 4B). On the other hand, energy expenditure as assessed
by oxygen consumption corrected per lean body mass during
indirect calorimetry was not significantly altered in female
MyD88DCNS mice compared to controls both at 4 and 12 weeks
of age, and male MyD88DCNS mice only exhibited increased
energy expenditure during nighttime at 12 weeks of age (Figures
4C and 4D). Moreover, there were no consistent, significant
alterations in spontaneous locomotor activity in MyD88DCNS
mice (Figures 4E and 4F). Thus, the mechanism underlying
protection from HFD-induced obesity in MyD88DCNS micenc.
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mice.
MyD88DCNS Mice Exhibit Increased Leptin Sensitivity
Given the occurrence of leptin resistance upon acute palmitate
injection in control mice and the protection of MyD88DCNS mice
from HFD-induced weight gain, we next asked whether leptin
action is altered in MyD88DCNS mice. Therefore, we subjected
control and MyD88DCNS mice that had been exposed to HFD to
a series of twice-daily saline injections followed by twice-daily
injections of mouse recombinant leptin. Leptin failed to signifi-
cantly reduce food intake in female control mice, but it signifi-
cantly reduced food intake in female MyD88DCNS mice exposed
to HFD (Figure 5A). Similarly, whereas leptin reduced food intake
inmale controlmiceby13.4%, it significantly reduced food intake
in male MyD88DCNS mice by 34.2% (Figure S3). Similarly, acute
intravenous injection of leptin failed to significantly activate
Stat3 phosphorylation in the arcuate nucleus of control mice
exposed to HFD, whereas leptin’s ability to activate Stat3
phosphorylation was restored in MyD88DCNS mice (Figures 5B
and 5C). Because restoration of leptin sensitivity in mice that
areprotected fromHFD-inducedweight gainmaybeconfounded
Figure 4. Decreased Food Intake in MyD88DCNS
Mice on High-Fat Diet
(A) Daily food intake of male (n = 7–14) and female (n = 7–
11) control and MyD88DCNS mice on high-fat diet at the
age of 4 weeks.
(B) Daily food intake of male (n = 11–13) and female (n = 5–
7) control and MyD88DCNS mice on high-fat diet at the age
of 12 weeks.
(C) Oxygen consumption (VO2) of male (n = 7–14) and
female (n = 7–11) control and MyD88DCNS mice on high-
fat diet at the age of 4 weeks.
(D) Oxygen consumption (VO2) of male (n = 5–8) and
female (n = 7) control and MyD88DCNS mice on high-fat
diet at the age of 12 weeks.
(E) Spontaneous locomotor activity of male (n = 7–14) and
female (n = 7–11) control and MyD88DCNS mice on high-fat
diet at the age of 4 weeks.
(F) Spontaneous locomotor activity of male (n = 5–8) and
female (n = 7) control and MyD88DCNS mice on high-fat
diet at the age of 12 weeks.
Displayed values are means ± SEM. *p% 0.05.
by the reduced body weight, we next performed
similar experiments in mice that had been
exposed to HFD only for 2 weeks and thus, at
the time of assessing leptin sensitivity, still
exhibited comparable body weight (Figure 5D).
Whereas leptin treatment still inhibited food
intake by 30% in control mice that had been
exposed to HFD for 2 weeks, the anorexigenic
action of leptin in MyD88DCNS mice exposed to
HFD for the same period was significantly more
pronounced and reduced food intake by 55%
(Figure 5E). Thus, disruption of MyD88-depen-
dent signaling in the CNS improved leptin sensi-
tivity in mice exposed to high-caloric diet, even
before differences in body weight were present.
On the other hand, whereas MyD88DCNS mice exhibited an
improved response to leptin, steady-state mRNA expression of
POMC, NPY, and AgRP remained unaltered in MyD88DCNS
mice compared to controls (Figure S4).
Given the reversal of HFD-induced leptin resistance in
MyD88DCNS mice with respect to both Stat3 phosphorylation
and anorexigenic action, we next aimed to investigate whether
CNS-restricted MyD88 deletion also affects the ability of
palmitate to inhibit leptin-stimulated Stat3 phosphorylation
upon injection. To this end, we compared the effect of combined
icv treatment with palmitate and leptin in lean control and
MyD88DCNS mice. Interestingly, disruption of MyD88 largely
enhanced hypothalamic leptin-stimulated Stat3 phosphorylation
in the presence of palmitate in MyD88DCNS compared to control
mice (Figure 5F), indicating that palmitate-evoked leptin resis-
tance is mediated by MyD88-dependent signaling. Taken
together, these data clearly show thatMyD88 in the CNS is a crit-
ical mediator of leptin resistance evoked both by high-fat feeding
and by acute administration of saturated fatty acids in vivo.
To further investigate whether reduced weight gain of
MyD88DCNS mice in response to high-fat feeding is only accom-
panied by improved leptin action or whether these animalsCell Metabolism 10, 249–259, October 7, 2009 ª2009 Elsevier Inc. 253
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MyD88DCNS Mice on High-Fat Diet
(A) Changes in food intake after intraperitoneal leptin treat-
ment in control (n = 7) andMyD88DCNS (n = 7)mice on high-
fat diet at the age of 14 weeks. Data represent daily food
intake after a 3 day treatment with twice-daily injections
of saline or 2 mg/kg leptin.
(B) (Top) Western blot analysis of phosphorylated STAT3
and STAT3 in dissected arcuate nuclei of 16-week-old
control (n = 5) and MyD88DCNS (n = 5) mice, which were
intravenously injected with either saline or leptin and sacri-
ficed 30 min after the injection. (Bottom) Densitometrical
analysis of phosphorylated STAT3 of leptin-injected mice
(n = 4) as compared to mice injected with saline (n = 1).
(C) pSTAT3 immunohistochemistry of ARC neurons of
control and MyD88DCNS mice on normal chow diet (NCD)
or high-fat diet (HFD) was performed in overnight fasted
animals, which were intraperitoneally injected with either
saline or leptin and sacrificed 30 min after stimulation.
Arrows indicate neurons positive for pSTAT3 in each
panel. Blue (DAPI), DNA; green, pSTAT3.
(D) (Top) Average body weight of female control and
MyD88DCNS mice on HFD (n = 7–11) at the age of 5 weeks.
(Bottom) Leanmass and body fat content of female control
and MyD88DCNS mice on HFD (n = 7–11) at the age of
5 weeks, as measured by nuclear magnetic resonance.
(E) Changes in food intake after intraperitoneal leptin
treatment in control (n = 4) and MyD88DCNS (n = 3) mice
on high-fat diet at the age of 5 weeks. Data represent daily
food intake after a 3 day treatment with twice-daily injec-
tions of saline or 2 mg/kg leptin.
(F) (Top) Western blot analysis of phosphorylated STAT3
and STAT3 in dissected arcuate nuclei of 10-week-old
control (n = 7) and MyD88DCNS (n = 3) mice, which were
ICV injected with palmitate (66 pmol) 30 min prior to
ICV injection of leptin (500 ng). (Bottom) Densitometrical
analysis of phosphorylated STAT3 of palmitate- + leptin-
injected MyD88DCNS mice (n = 3) as compared to palmi-
tate- + leptin-injected control mice (n = 7).
(G) Male control (n = 9) and MyD88DCNS (n = 9) mice on
HFD were intraperitoneally injected at the onset of the
dark cycle with saline or MTII at the age of 13 weeks.
Cumulative food intake and body weight were measured
2, 4, and 24 hr after injection.
Displayed values are means ± SEM. *p % 0.05,
**p% 0.01, and ***p % 0.001.may exhibit different responses to other anorexigenic signals, we
nextcompared theanorexigenic andbodyweight-reducingeffect
of the melanocortin (MC)-4 receptor agonist melanotan (MTII).
This analysis revealed improved anorexigenic and weight-
reducing effect of MTII in MyD88DCNSmice compared to controls
(Figure 5G). Thus, MyD88 disruption not only improved leptin, but
also melanocortin signaling in mice exposed to high-fat diet.
Ameliorated IKK Activation in MyD88DCNS Mice
To investigate whether obesity-induced IKK and possibly JNK
activation in the hypothalamus occurs as a consequence of
fatty acid-activated, TLR- and MyD88-dependent signaling, we
compared the expression and activation of IKKs and JNK in
the hypothalami of control and MyD88DCNS mice, which had
been exposed for 12 weeks to HFD. Immunoblot analysis with
antibodies, which recognize IKKs, when phosphorylated at
serine residues 176/180 as a marker of activation (DiDonato
et al., 1997), revealed substantial IKK phosphorylation in extracts254 Cell Metabolism 10, 249–259, October 7, 2009 ª2009 Elsevier Iof arcuate nuclei of control, whereas IKK phosphorylation was
slightly reduced in extracts isolated from MyD88DCNS mice,
even though total immunoreactive IKKs were clearly increased
in the extracts of MyD88DCNS mice (Figure 6A). Next, we investi-
gated the regulation of IkBa expression and phosphorylation.
IKK-dependent phosphorylation targets IkBa for proteasomal
degradation, thus allowing for nuclear translocation of NFkB.
Comparison of IkBa expression in hypothalamic extracts from
HFD-fed control and MyD88DCNS mice revealed a significant
increase of IkBa expression but significantly reduced phosphor-
ylation in hypothalamic extracts from MyD88DCNS mice
compared to controls (Figure 6B). Taken together, these data
demonstrate that MyD88 deletion reduces IKK activation in the
hypothalamus of obese mice.
In contrast, analysis of JNK phosphorylation in hypothalami of
MyD88DCNS mice revealed both a decrease in immunoreactive
phosphorylated, as well as total, JNK protein compared to
controls (Figure 6C). Thus, JNK activation remained unalterednc.
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proinflammatory cytokines, such as TNF and IL-6, as well as
markers of ER stress, such as GRP78, spliced XBP, and CHOP,
remained unaltered in HFD-fed MyD88DCNS mice compared to
controls (Figures S5A and S5B).
Thus, improved leptin sensitivity in the presence of unaltered
JNK activity indicated that JNK activation is not responsible for
induction of diet-induced leptin resistance. Because hypotha-
lamicJNKactivationoccursuponHFD-inducedobesity (DeSouza
etal., 2005;Wonet al., 2009) (B.F.B. andJ.C.B., unpublisheddata)
and to directly test the role of JNK-dependent signaling in the
development of diet-induced leptin resistance, we compared
the food intake- and body weight-reducing effect of leptin in
control mice and those with targeted disruption of JNK1, specifi-
cally in the CNS (B.F.B. and J.C.B., unpublished data). This anal-
ysis indicated that leptin failed to significantly reduce both food
intake and body weight in either control or brain-specific JNK1
knockout mice exposed to HFD (Figure 6D), consistent with unal-
tered food intake and body composition of these mice upon HFD
exposure (B.F.B. and J.C.B., unpublished data). Taken together,
MyD88 ablation in the CNS abrogates high-fat diet-induced IKK,
but not JNK, activation in the hypothalamus of mice, assigning
MyD88-dependent signaling a crucial role in diet-induced inflam-
matory signaling not only inperipheral tissues, but also in theCNS.
Figure 6. MyD88DCNS Mice Are Protected
from High-Fat Diet-Induced IKK Activation
(A) (Top) Western blot analysis of phosphorylated
IKK and IKK in dissected arcuate nuclei of 16-
week-old control (n = 5) and MyD88DCNS (n = 5)
mice. (Bottom) Densitometrical analysis of phos-
phorylated IKK of MyD88DCNS mice as compared
to control mice.
(B) (Top) Western blot analysis of phosphorylated
IkBa and IkBa in dissected arcuate nuclei of 16-
week-old control (n = 5) and MyD88DCNS (n = 5)
mice. (Bottom) Densitometrical analysis of phos-
phorylated IkBa of MyD88DCNS mice as compared
to control mice.
(C) (Top) Western blot analysis of phosphorylated
JNK and JNK in dissected arcuate nuclei of 16-
week-old control (n = 5) and MyD88DCNS (n = 5)
mice. (Bottom) Densitometrical analysis of phos-
phorylated JNK of MyD88DCNS mice as compared
to control mice.
(D) Changes in food intake and body weight after
intraperitoneal leptin treatment in control (n = 8)
and JNK1DCNS (n = 8) mice on high-fat diet at the
age of 13 weeks. Data represent daily food intake
after a 3 day treatment with twice-daily injections
of saline or 2 mg/kg leptin. Body weight was
measured twice a day.
M, molecular weight marker. Displayed values are
means ± SEM. **p% 0.01 and ***p% 0.001.
Improved Insulin Action in
MyD88DCNS Mice
To investigate the effect of CNS-specific
disruption of MyD88 and subsequently
that of IKK activation in the hypothal-
amus on peripheral glucose metabolism
upon exposure to HFD, we next com-
pared blood glucose and plasma insulin concentrations in
control and MyD88DCNS mice. Whereas control mice exposed
to HFD developed significantly impaired glucose tolerance in
the presence of pronounced hyperinsulinemia compared to
mice exposed to NCD (Figures 3A–3F), HFD-induced impairment
of glucose and insulin tolerance, as well as insulin concentra-
tions, was largely blunted in male and female MyD88DCNS mice
(Figures 3A–3F). Taken together, ablation of the TLR adaptor
MyD88 in the CNS ameliorated whole-body insulin sensitivity
during the course of diet-induced obesity.
To further investigate the contribution of chronic MyD88-
dependent, palmitate-evoked signaling in the CNS to the
phenotype of HFD-fed animals, we next compared the effect
of chronic palmitate icv infusion over a period of 2 weeks in
control and MyD88DCNS mice. Whereas palmitate infusion
did not significantly alter fat mass and food intake over the
2 week period in control animals (Figures 7A and 7B), central
palmitate infusion compared to BSA infusion significantly
impaired insulin tolerance in control mice (Figure 7C). Strik-
ingly, whereas brain-specific disruption of MyD88 again did
not affect fat mass and food intake in palmitate-infused
animals (Figures 7D and 7E), palmitate-induced insulin resis-
tance was blunted in MyD88DCNS mice compared to controls
(Figure 7F).Cell Metabolism 10, 249–259, October 7, 2009 ª2009 Elsevier Inc. 255
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tance Is Blunted in MyD88DCNS Mice
(A) Epigonadal fat pad weights of wild-type mice
on normal chow diet that were chronically infused
icv with either BSA (n = 13) or palmitate (n = 13)
during a period of 2 weeks.
(B) Total food intake of wild-type mice on normal
chow diet that were chronically infused icv with
either BSA (n = 13) or palmitate (n = 13) during
a period of 2 weeks.
(C) Intraperitoneal insulin tolerance test in wild-
type mice on normal chow diet that were
chronically infused icv with either BSA (n = 13) or
palmitate (n = 13) during a period of 2 weeks.
(D) Epigonadal fat pad weights of control (n = 15)
and MyD88DCNS (n = 9) mice on normal chow
diet that were chronically infused icv with palmi-
tate during a period of 2 weeks.
(E) Total food intake of control (n = 15) and
MyD88DCNS (n = 9) mice on normal chow diet
that were chronically infused icv with palmitate
during a period of 2 weeks.
(F) Intraperitoneal insulin tolerance test in control
(n = 15) and MyD88DCNS (n = 9) mice on normal
chow diet that were chronically infused icv with
palmitate during a period of 2 weeks.
Displayed values are means ± SEM. *p% 0.05.DISCUSSION
Resistance to leptin and insulin action in the CNS represents
a hallmark during the development of high-caloric diet-induced
weight gain and peripheral insulin resistance (Schwartz and
Porte, 2005). Here, we demonstrate that palmitate, an abundant
fatty acid in the circulation that is also increased in the hypothal-
amus upon high-fat feeding (Posey et al., 2009), acutely causes
leptin resistance in the CNS. These findings extend those
recently published by Milanski et al., demonstrating that central
application of stearic and arachidic acid activate proinflamma-
tory gene expression in the hypothalamus in a TLR-dependent
manner (Milanski et al., 2009).
Saturated fatty acids represent important candidates for
causing diet-induced leptin and insulin resistance. Saturated,
but not unsaturated, fatty acids act as ligands for TLR4 (Lee
et al., 2001), thus activating JNK- and IKK-signaling cascades,
both of which inhibit insulin action (Hirosumi et al., 2002; Arkan
et al., 2005).
Consistent with a role for palmitate in obesity-associated
insulin resistance, there is evidence that mice with impaired
TLR4 expression are protected from obesity-associated insulin
resistance (Poggi et al., 2007; Shi et al., 2006; Tsukumo et al.,
2007), whereas body weight under HFD conditions is either
increased (Shi et al., 2006), decreased (Tsukumo et al., 2007),
or unchanged (Kim et al., 2007; Poggi et al., 2007) in these
animals compared to controls. The reasons for these different
findings are unclear but may be accounted for by different
genetic backgrounds, diet composition, or different environ-
mental factors. Interestingly, TLR4 disruption selectively pro-
tected from high-fat diet-induced insulin resistance caused by
saturated, but not unsaturated, fatty acids (Davis et al., 2008),
consistent with a pivotal role for palmitate in high-fat diet-
induced, obesity-associated insulin resistance. Disruption of256 Cell Metabolism 10, 249–259, October 7, 2009 ª2009 Elsevier ITLR2 also protects from obesity-associated insulin resistance
and palmitate-induced insulin resistance in cultured skeletal
muscle cells (Senn, 2006; Caricilli et al., 2008). These experi-
ments point toward redundancy among different TLRs in
mediating the insulin resistance-inducing effect of fatty acids.
Consistent with redundant action of TLR2 and TLR4 in fatty
acid-induced gene expression, Milanski et al. demonstrate that
both TLR2- and TLR4-blocking antibodies attenuate fatty acid
induction of hypothalamic proinflammatory gene expression
(Milanski et al., 2009).
Our experiments directly demonstrate that the pharmacolog-
ical effect of palmitate in causing leptin resistance depends
on MyD88-activated signaling. Because MyD88 serves as an
adaptor molecule to mediate both TLR and IL-1 receptor-acti-
vated NFkB and JNK signaling, our experiments cannot formally
exclude the possibility that palmitate-induced leptin resistance is
mediated by the IL-1 receptor. Whereas leptin-induced anorexia
has been demonstrated to be abolished in IL-1 receptor
knockout mice (Luheshi et al., 1999), physiological effects of lep-
tin on energy balance seem to be independent of IL-1 signaling
(Wisse et al., 2007). Nevertheless, impairment of IL-1 signaling
in MyD88DCNS mice probably does not account for leptin sensi-
tization in these animals. Taken together with the experiments on
TLR-blocking antibodies (Milanski et al., 2009), we conclude that
palmitate induces leptin resistance via TLR-activated MyD88-
dependent signals.
Our study also offers important evidence for the nature of the
downstream mediator of palmitate-induced, MyD88-dependent
leptin resistance upon high-fat feeding. Only activation of IKK,
deletion of which in the CNS has recently been demonstrated
to rescue obesity-associated leptin resistance (Zhang et al.,
2008), is significantly reduced in hypothalami of MyD88DCNS
mice exposed to high-fat diet. Although JNK signaling also
represents a candidate pathway for palmitate-mediated leptinnc.
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tion of Stat3 (Lim and Cao, 1999), the presence of unaltered
JNK activation in hypothalami of MyD88DCNS mice, which are
protected from obesity, indicates that JNK signaling is not
responsible for mediating leptin resistance upon HFD feeding
in these mice. Importantly, this notion is further directly sup-
ported by our experiments, revealing that CNS-specific disrup-
tion of JNK1 fails to improve diet-induced leptin resistance.
Moreover, our experiments indicate that stimuli other than palmi-
tate in MyD88-deficient mice are responsible for high-fat diet-
induced chronic JNK-activation.
Consistent with the role of palmitate- and diet-induced
MyD88-dependent IKK activation in causing leptin resistance,
Posey et al. recently demonstrated that palmitate can acutely
cause insulin resistance in the CNS and that this effect can be
reversed by pharmacological inhibition of IKK-dependent
signaling (Posey et al., 2009). Although the authors of this study
do not provide evidence for the signaling pathway involved, our
results clearly indicate that palmitate-induced IKK activation and
IkBa degradation critically depend on MyD88. On the other
hand, the absence of alterations in proinflammatory gene
expression in our model argue for a role of IKK-dependent, but
potentially NFkB-independent, signaling in the induction of
insulin and leptin resistance. Alternatively, unaltered JNK activa-
tionmay account for unaltered proinflammatory gene expression
even in the presence of reduced IKK activation. Thus, in addition
to the reversal of leptin resistance in the CNS of MyD88DCNS
mice, these animals are predicted to be protected also from
palmitate-induced neuronal insulin resistance. Because we
and others have previously demonstrated that insulin action in
the CNS (Bruning et al., 2000; Koch et al., 2008; Obici et al.,
2002), particularly in AgRP-expressing neurons (Konner et al.,
2007), is critical for control of peripheral glucose metabolism,
mainly via suppression of hepatic glucose production, the
disproportional improvement of glucose metabolism in male
MyD88DCNS mice—despite only minor reduction of fat content
and body weight—indeed indicates improved insulin action in
the CNS of these mice. Though at this point, we cannot define
the underlying mechanism for the gender-specific effect of
CNS-restricted MyD88 disruption on obesity development, our
data are consistent with multiple knockout experiments target-
ing signaling pathways involved in the regulation of energy
homeostasis that yielded as-yet unexplained gender-specific
phenotypes (Alfadda et al., 2004; Bruning et al., 2000; Lewitt
and Brismar, 2002; Plum et al., 2006b).
Nevertheless, differential improvement of leptin and insulin
sensitivity is further supported by our results obtained upon
chronic icv palmitate infusion. Also, in this experimental para-
digm, central MyD88 deficiency preferentially restores peripheral
insulin sensitivity, even when body weight regulation is not
affected. The differential sensitivity of body weight regulation
and control of peripheral glucose metabolism may stem from
the differential responsiveness of neuronal leptin and insulin
signaling toward inhibition by fatty acid-induced MyD88-depen-
dent signaling. Thus, in the chronic infusion paradigm, higher
palmitate doses might be required to induce leptin resistance
and weight gain in the long term, as seen under high-fat diet
conditions. Nevertheless, our study clearly reveals a critical
role for MyD88-dependent signaling in the CNS in developmentCelof fatty acid- and high-fat diet-induced leptin and insulin resis-
tance in vivo.
Moreover, the finding that neuronal MyD88 disruption also
improves melanocortin sensitivity clearly deserves further
studies. These findings implicate that MyD88-dependent
signaling impairs leptin and insulin action in the arcuate nucleus,
as well as in downstream neurons in the circuitry such as MC4R-
positive PVN neurons.
Intranasal application of small peptides results in selective
increase of cerebrospinal concentrations without reaching
significant concentrations in circulation (Born et al., 2002).
Thus, this route may serve as a new approach to deliver small
inhibitors of TLR/MyD88 interaction, potentially setting the
ground for novel therapeutic interventions with the obesity
epidemic, without impairing systemic pathogen defense mecha-
nisms.
EXPERIMENTAL PROCEDURES
Generation of MyD88DCNS Mice
The generation of the conditional allele of MyD88 (MGI: 108005) will be
described in detail in a separate publication. In brief, the essential TIR
domain-encoding exons 3–5 were flanked with loxP sites in C57/BL6-derived
embryonic stem (ES) cells in order to render MyD88 susceptible to Cre-medi-
ated recombination. The resulting MyD88lox mice were then crossed to mice
expressing Cre under the CNS-specific rat nestin promoter (Bruning et al.,
2000) to yield MyD88lox/lox; NesCre+/ mice (termed MyD88DCNS mice).
MyD88lox/lox mice were used as control. Breeding colonies were maintained
by mating MyD88lox/lox with NesCre-MyD88lox/lox mice. NesCre mice had
been backcrossed for at least five generations on a C57BL/6 background
before intercrossing them with MyD88lox/lox mice. Thus, C57/BL6 alleles
accounted for more than 98% of genes in the experimental mice. Mice were
genotyped by PCR using genomic DNA isolated from tail tips.NesCre primers:
NesCre 50, 50-CGC TTC CGC TGG GTC ACT GTC G-30; NesCre 300, 50-TCG
TTG CAT CGA CCG GTA ATG CAG GC-30. MyD88 primers: Seq19, 50-GGG
AAT AAT GGC AGT CCT CTC CCA G-30; Seq20, 50-GGA TCA TCT CCT
GCA CAA ACT CG-30. Germline deletion of NesCre was excluded with a dele-
tion PCR using two primers, one binding upstream of the first loxP site and the
others flanking the second loxP site: Seq19, 50-GGG AAT AAT GGC AGT CCT
CTC CCA G-30; Seq16, 50-C AGT CTC ATC TTC CCC TCT GCC-30.
Body Composition
Body fat content was measured in vivo by nuclear magnetic resonance using
a minispec mq 7.5 (Bruker Optics).
Western Blot Analysis
Indicated tissues were dissected and homogenized in homogenization buffer
with a polytron homogenizer (IKAWerke), and western blot analyses were per-
formed as previously described (Schubert et al., 2004) with antibodies raised
against MyD88 (#2068, Abcam) and a-tubulin (#T6074, Sigma) as loading
control. Arcuate nuclei were dissected and homogenized with a mortar, and
western blot analyses were performed with antibodies raised against pSTAT3
(#9451, Cell Signaling), STAT3 (#4904, Cell Signaling), pIKKa/b (#2697, Cell
Signaling), IKKb (#2370, Cell Signaling), pIkBa (#9241, Cell Signaling), IkBa
(#9242, Cell Signaling), JNK (#9252, Cell Signaling), pJNK (#9251, Cell
Signaling), Grp78 (#sc 13968, Santa Cruz), GADD153 (CHOP) (#sc 7351, Santa
Cruz), Xbp1 (# sc 7160, Santa Cruz), and b-actin (#A5441, Sigma).
Intracerebroventricular Experiments
For icv cannula implantation, 10-week-old male C57BL/6 (Charles River Labo-
ratories), control (MyD88lox/lox), and MyD88DCNS mice were anesthetized by
intraperitoneal injection of Avertin (650 mg/kg) (2,2,2-tribromoethanol; Sigma)
and placed in a stereotactic device. A sterile osmotic pump connector cannula
(Bilaney Consultants) was implanted into the left lateral brain ventricle
(–0.2 mm anterior and 1.0 mm lateral relative to Bregma and 2.3 mm belowl Metabolism 10, 249–259, October 7, 2009 ª2009 Elsevier Inc. 257
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CNS-Restricted MyD88 Knockoutthe surface of the skull). The support plate of the catheter was attached to the
skull with Super Glue (Super Glue Corp.). The catheter was prefilled with 0.9%
saline and connected to a sealed microrenathane catheter (MRE-025; Brain-
tree Scientific Inc.). After 5 days of recovery, mice were fasted overnight,
and the sealed microrenathane catheter was removed. Palmitate (10, 20, 50,
or 66 pmol), vehicle (BSA), leptin (500 ng), or vehicle (0.9% saline) was injected
in a volume of 2 ml according to the respective experimental set-up (see
Figure 1). The catheter was subsequently sealed to avoid backflow. Injections
were performed in isoflurane anesthesia. Palmitate solutions were prepared as
previously described (Listenberger et al., 2001).
Statistical Methods
Data sets were analyzed for statistical significance using a two-tailed unpaired
student’s T test. P values less than 0.05 were considered significant.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five
figures and can be found with this article online at http://www.cell.com/
cell-metabolism/S1550-4131(09)00263-0.
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